novo nordisk weight loss news - Search News

Novo Nordisk Posts Mixed Results

Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs.

Barron's on MSN · 4d

Novo Nordisk Posts Mixed Results, Adding to Jitters About Weight-Loss Drugs

A mixed sales report for Novo Nordisk’s GLP-1 megablockbuster drugs failed to quiet concerns Wednesday that investors may have overestimated the market for its new weight-loss and diabetes medicines.

Fast Company · 6d

Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded market

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked in traditional channels.

10h

Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem ...

Weight-loss pill passes important safety test in clinical trial

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Fortune on MSN6d

Danish town where weight-loss wonder drug Ozempic is made suffers from the highest rates of overweight children in Denmark

A more tragic irony in the town is an obesity crisis among residents living in the shadow of the massive Wegovy-making plant.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results